RESUMO
Assessment of thymic output by measurement of naive T cells is carried out routinely in clinical diagnostic laboratories, predominantly using flow cytometry with a suitable panel of antibodies. Naive T cell measurements can also be made using molecular analyses to quantify T cell receptor excision circle (TRECs) levels in sorted cells from peripheral blood. In this study we have compared TRECs levels retrospectively with CD45RA+ CD27+ T cells and also with CD45RA+ CD31+ T cells in 134 patient samples at diagnosis or during follow-up. Both panels provide naive T cell measurements that have a strongly positive correlation with TRECs numbers and are suitable for use with enumerating naive T cell levels in a clinical laboratory.
Assuntos
Células Sanguíneas/imunologia , Citometria de Fluxo/métodos , Técnicas de Diagnóstico Molecular/métodos , Receptores de Antígenos de Linfócitos T/genética , Subpopulações de Linfócitos T/imunologia , Linfócitos T/imunologia , Seguimentos , Humanos , Memória Imunológica , Antígenos Comuns de Leucócito/metabolismo , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Estudos Retrospectivos , Membro 7 da Superfamília de Receptores de Fatores de Necrose Tumoral/metabolismoRESUMO
Trypanosoma brucei, the protozoan parasite responsible for African sleeping sickness, evades the host immune response through the process of antigenic variation. The variant antigen, known as the variant surface glycoprotein (VSG), is anchored to the cell surface by a glycosyl phosphatidylinositol (GPI) structure that contains myristate (n-tetradecanoate) as its only fatty acid component. The utilization of heteroatom-containing analogs of myristate was studied both in a cell-free system and in vivo. Results indicated that the specificity of fatty acid incorporation depends on chain length rather than on hydrophobicity. One analog, 10-(propoxy)decanoic acid, was highly toxic to trypanosomes in culture although it is nontoxic to mammalian cells.
Assuntos
Ácidos Mirísticos/metabolismo , Ácidos Mirísticos/farmacologia , Trypanosoma brucei brucei/efeitos dos fármacos , Acil Coenzima A/metabolismo , Animais , Sistema Livre de Células , Glicolipídeos/metabolismo , Glicosilfosfatidilinositóis , Cinética , Camundongos , Ácido Mirístico , Fosfatidilinositóis/metabolismo , Relação Estrutura-Atividade , Trypanosoma brucei brucei/metabolismo , Trypanosoma brucei brucei/ultraestruturaRESUMO
Mammalian cardiac atria have several biologically active peptides that exert profound effects on sodium excretion, urine volume, and smooth muscle tone. In the present study two such peptides of low molecular weight were purified and separated from each other on the basis of differences in charge, hydrophobicity, and biological profile. The first peptide, designated atriopeptin I, exhibits natriuretic and diuretic activity and selectivity relaxes intestinal smooth muscle but not vascular smooth muscle strips. The second peptide, atriopeptin II, is a potent natriuretic and diuretic that relaxes both intestinal and vascular strips. Sequence analysis of atriopeptin I indicates that it is composed of 21 amino acids, of which serine and glycine residues predominate. The amino terminal sequence of atriopeptin II up to residue 21 is the same as that of atriopeptin I, with the addition of the Phe-Arg extension at the carboxyl terminus. Both peptides appear to be derived from a common high molecular weight precursor (designated atriopeptigen); their biological selectivity and potency may be determined by the site of carboxyl terminal cleavage.
Assuntos
Átrios do Coração/análise , Peptídeos/isolamento & purificação , Sequência de Aminoácidos , Animais , Arginina/análise , Cromatografia Líquida de Alta Pressão , Cromatografia por Troca Iônica , Diurese/efeitos dos fármacos , Glicina/análise , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Natriurese/efeitos dos fármacos , Peptídeos/análise , Peptídeos/farmacologia , Fenilalanina/análise , Ratos , Serina/análiseRESUMO
Cancer testis (CT) antigens provide attractive targets for cancer-specific immunotherapy. Although CT genes are expressed in some normal tissues, such as the testis and in some cases placenta, these immunologically protected sites lack MHC I expression and as such, do not present 'self' antigens to T cells. To date, CT genes have been shown to be expressed in a range of solid tumours, but rarely in haematological malignancies. We have extended previous studies to investigate the expression of a comprehensive range of CT genes (MAGE-A1, -A3, -A6, -A12, BAGE, GAGE, HAGE,LAGE-1, NY-ESO-1 and RAGE) for their expression in a cohort of acute and chronic myeloid leukaemia patient samples. CT expression was not detected in 20 normal bone marrow or peripheral blood stem cell samples. In acute myeloid leukaemia (AML) nine of the 26 (35%) samples analysed expressed one or more of the CT genes with six of the samples (23%) expressing HAGE. In chronic myeloid leukaemia (CML) 24 of 42 (57%) presentation chronic myeloid leukaemia (CML) patient samples expressed one or more CT antigen with 23 expressing HAGE. We have shown that HAGE is frequently expressed in CML, and to a lesser extent in AML patient samples. This is the first demonstration of HAGE gene expression in myeloid leukaemia patients and the frequent expression of HAGE at disease presentation opens up the possibility of early immunotherapeutic treatments.
Assuntos
Antígenos de Neoplasias/genética , DNA Helicases , Leucemia Mielogênica Crônica BCR-ABL Positiva/genética , Proteínas de Neoplasias/genética , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Células da Medula Óssea/fisiologia , Estudos de Casos e Controles , RNA Helicases DEAD-box , DNA de Neoplasias/análise , Regulação Neoplásica da Expressão Gênica , Humanos , Leucemia Mielogênica Crônica BCR-ABL Positiva/imunologia , Masculino , Pessoa de Meia-Idade , RNA Neoplásico/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Testículo/metabolismo , Testículo/patologia , Células Tumorais CultivadasRESUMO
BACKGROUND AND PURPOSE: The present study was performed to determine the role of alpha4 (CD49d), a member of the integrin family of adhesion molecules, in ischemic brain pathology. METHODS: Male spontaneously hypertensive rats (SHR) or Sprague-Dawley rats underwent 60-minute middle cerebral artery occlusion (MCAO) followed by 23-hour reperfusion. Animals were injected intravenously with 2.5 mg/kg anti-rat alpha4 antibody (TA-2) or isotype control antibody (anti-human LFA-3 IgG(1), 1E6) 24 hours before MCAO. Infarct volume was quantified by staining of fresh tissue with tetrazolium chloride and myeloperoxidase activity measured in SHR tissue homogenates 24 hours after MCAO. In SHR, mean arterial blood pressure was recorded before and after MCAO in animals treated with TA-2 and 1E6. Fluorescence-activated cell sorting analysis was performed on peripheral blood leukocytes before and after MCAO. RESULTS: TA-2 treatment significantly reduced total infarct volume by 57.7% in normotensive rats (1E6, 84.2+/-11.5 mm(3), n=17; TA-2, 35.7+/-5.9 mm(3), n=16) and 35.5% in hypertensive rats (1E6, 146.6+/-15.5 mm(3), n=15; TA-2, 94.4+/-25.8 mm(3), n=11). In both strains, TA-2 treatment significantly reduced body weight loss and attenuated the hyperthermic response to MCAO. In SHR, treatment with TA-2 significantly reduced brain myeloperoxidase activity. Resting mean arterial blood pressure was unaffected by treatment. Leukocyte counts were elevated in TA-2-treated rats. Fluorescence-activated cell sorting analysis demonstrated the ability of TA-2 to bind to CD3+, CD4+, CD8+, and CD11b+ cells in both naive animals and after MCAO. CONCLUSIONS: These data demonstrate that inhibition of alpha4 integrin can protect the brain against ischemic brain injury and implicate endogenous alpha4 integrin in the pathogenesis of acute brain injury. The mechanism by which alpha4 integrin inhibition offers cerebroprotection is independent of blood pressure modulation and is likely due to inhibition of leukocyte function.
Assuntos
Antígenos CD/metabolismo , Infarto Cerebral/prevenção & controle , Ataque Isquêmico Transitório/metabolismo , Animais , Anticorpos/farmacologia , Antígenos CD/imunologia , Antígenos CD/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Temperatura Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Encéfalo/enzimologia , Encéfalo/patologia , Moléculas de Adesão Celular/antagonistas & inibidores , Moléculas de Adesão Celular/imunologia , Moléculas de Adesão Celular/metabolismo , Infarto Cerebral/etiologia , Infarto Cerebral/metabolismo , Infarto Cerebral/patologia , Modelos Animais de Doenças , Citometria de Fluxo , Infarto da Artéria Cerebral Média/complicações , Integrina alfa4 , Ataque Isquêmico Transitório/etiologia , Ataque Isquêmico Transitório/imunologia , Ataque Isquêmico Transitório/patologia , Contagem de Leucócitos , Leucócitos/citologia , Leucócitos/efeitos dos fármacos , Leucócitos/imunologia , Masculino , Peroxidase/metabolismo , Ratos , Ratos Endogâmicos SHR , Ratos Sprague-Dawley , Reprodutibilidade dos TestesRESUMO
We studied the effect of isoniazid administration on the cytochrome P4502E1-catalyzed elimination of chlorzoxazone and acetaminophen. Isoniazid, 300 mg daily, was administered for 7 days to a group of 10 volunteer slow acetylators. Acetaminophen, 500 mg, and chlorzoxazone, 750 mg, were administered on separate occasions before isoniazid, during the period of isoniazid administration, and after the discontinuation of isoniazid. Isoniazid inhibited the clearance of chlorzoxazone by 58%, as assessed from plasma data, and inhibited the formation of acetaminophen thioether metabolites (a measure of the formation of the hepatotoxin N-acetyl-p-benzoquinone imine and catechol oxidative metabolites of acetaminophen, as determined from their recovery in urine, by 63% and 49%, respectively. Two days after the discontinuation of isoniazid, the clearance of chlorzoxazone was increased over the value before isoniazid by 56%. Acetaminophen thioether but not catechol metabolites were increased by 56% 1 day after the discontinuation of isoniazid and had returned to the pre-isoniazid value 3 days after the discontinuation of isoniazid. We conclude that the time course of the interaction with regard to chlorzoxazone elimination and formation is compatible with an inhibition-induction effect of isoniazid on cytochrome P4502E1. The mechanism of this biphasic effect is probably induction by protein stabilization, which results in inhibition of catalytic activity while isoniazid is present.
Assuntos
Acetaminofen/metabolismo , Sistema Enzimático do Citocromo P-450/biossíntese , Isoniazida/farmacologia , Oxirredutases N-Desmetilantes/biossíntese , Acetaminofen/urina , Acetilação , Adulto , Clorzoxazona/farmacocinética , Citocromo P-450 CYP2E1 , Inibidores das Enzimas do Citocromo P-450 , Indução Enzimática/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Oxirredutases N-Desmetilantes/antagonistas & inibidores , Fenótipo , Sulfametazina/sangue , Sulfametazina/farmacocinética , Sulfametazina/urinaRESUMO
Synthetic high- and low-molecular-mass atrial peptides were phosphorylated in vitro by cyclic AMP-dependent protein kinase and [32P]ATP. From a series of atrial peptide analogs, it was deduced that the amino acid sequence, Arg101-Ser104 of atriopeptin was required for optimal phosphorylation. Phosphorylated AP(99-126) was less potent than the parent atriopeptin in vasorelaxant activity and receptor-binding properties. These results indicate that the presence of a phosphate group at the N-terminus of AP(99-126) decreases the interaction of the peptide with its receptor and, as a consequence, decreases bioactivity. These observations are in contrast to those of Rittenhouse et al. [(1986) J. Biol. Chem. 261, 7607-7610] who reported that phosphorylation of AP(101-126) enhanced the stimulation of Na/K/Cl cotransport in cultured vascular smooth muscle cells.
Assuntos
Fator Natriurético Atrial/análogos & derivados , Proteínas Quinases/metabolismo , Animais , Fator Natriurético Atrial/metabolismo , Membrana Celular/metabolismo , AMP Cíclico/metabolismo , Técnicas In Vitro , Pulmão , Peso Molecular , Fosforilação , Coelhos , Receptores do Fator Natriurético Atrial , Receptores de Superfície Celular/metabolismo , Relação Estrutura-Atividade , Compostos de Sulfidrila/metabolismoRESUMO
Integrin alpha4beta1 mediates leukocyte recruitment, activation, mediator release, and apoptosis inhibition, and it plays a central role in inflammatory pathophysiology. High-affinity, selective inhibitors of alpha4beta1, based on the Leu-Asp-Val (LDV) sequence from the alternatively spliced connecting segment-1 (CS-1) peptide of cellular fibronectin, are described that employ a novel N-terminal peptide "cap" strategy. One inhibitor, BIO-1211, was approximately 10(6)-fold more potent than the starting peptide and exhibited tight-binding properties (koff = 1.4 x 10(-4) s-1, KD = 70 pM), a remarkable finding for a noncovalent, small-molecule inhibitor of a protein receptor. BIO-1211 was also 200-fold selective for the activated form of alpha4beta1, and it stimulated expression of ligand-induced epitopes on the integrin beta1 subunit, a property consistent with occupancy of the receptor's ligand-binding site. Pretreatment of allergic sheep with a 3-mg nebulized dose of BIO-1211 inhibited early and late airway responses following antigen challenge and prevented development of nonspecific airway hyperresponsiveness to carbachol. These results show that highly selective and potent small-molecule antagonists can be identified to integrins with primary specificity for peptide domains other than Arg-Gly-Asp (RGD); they confirm the generality of integrins as small molecule targets; and they validate alpha4beta1 as a therapeutic target for asthma.
Assuntos
Antialérgicos/síntese química , Hiper-Reatividade Brônquica/prevenção & controle , Integrinas/antagonistas & inibidores , Oligopeptídeos/síntese química , Receptores de Retorno de Linfócitos/antagonistas & inibidores , Animais , Antialérgicos/química , Antialérgicos/metabolismo , Antialérgicos/farmacologia , Sítios de Ligação , Hiper-Reatividade Brônquica/induzido quimicamente , Hiper-Reatividade Brônquica/imunologia , Carbacol/toxicidade , Adesão Celular/efeitos dos fármacos , Linhagem Celular , Desenho de Fármacos , Epitopos , Fibronectinas/química , Fibronectinas/fisiologia , Humanos , Integrina alfa4beta1 , Integrinas/metabolismo , Células Jurkat , Cinética , Ligantes , Oligopeptídeos/química , Oligopeptídeos/metabolismo , Oligopeptídeos/farmacologia , Receptores de Retorno de Linfócitos/metabolismo , Ovinos , Relação Estrutura-Atividade , Molécula 1 de Adesão de Célula Vascular/fisiologiaRESUMO
Since its discovery, ANF has provided multitudinous opportunities to explore its relationship to various biologic functions. Hundreds of publications investigating various aspects of this newly discovered hormone system have appeared. ANF exhibits a plethora of direct and indirect biologic activities that oppose the hypervolemic and hypernatremic effects exerted by the renin-aldosterone-angiotensin system. Additionally, ANF and ANF receptors are present in the central and peripheral nervous system, and ANF administered in the brain exerts striking effects relating to vasopressin and water consumption. It thus appears that ANF functions as a neurotransmitter or neuromodulator in consort with its direct peripheral actions. One may anticipate that continued research will uncover more interesting biology and elucidate the interplay between ANF and various control systems responsible for volume and electrolyte homeostasis.
Assuntos
Fator Natriurético Atrial , Sequência de Aminoácidos , Animais , Fator Natriurético Atrial/isolamento & purificação , Fator Natriurético Atrial/metabolismo , Fator Natriurético Atrial/fisiologia , Dados de Sequência Molecular , Peso MolecularRESUMO
Fluorescent in situ hybridization and Southern blotting were used for showing the predominant absence of the Arabidopsis-type telomere repeat sequence (TRS) 5'-(TTTAGGG)(n)-3' (the 'typical' telomere) in a monocot clade which comprises up to 6300 species within Asparagales. Initially, two apparently disparate genera that lacked the typical telomere were identified. Here, we used the new angiosperm phylogenetic classification for predicting in which other related families such telomeres might have been lost. Our data revealed that 16 species in 12 families of Asparagales lacked typical telomeres. Phylogenetically, these were clustered in a derived clade, thereby enabling us to predict that the typical telomere was lost, probably as a single evolutionary event, following the divergence of Doryanthaceae ca. 80--90 million years ago. This result illustrates the predictive value of the new phylogeny, as the pattern of species lacking the typical telomere would be considered randomly placed against many previous angiosperm taxonomies. Possible mechanisms by which chromosome end maintenance could have evolved in this group of plants are discussed. Surprisingly, one genus, Ornithogalum (Hyacinthaceae), which is central to the group of plants that have lost the typical telomere, appears to have regained the sequences. The mechanism(s) by which such recovery may have occurred is unknown, but possibilities include horizontal gene transfer and sequence reamplification.
Assuntos
Arabidopsis/genética , Genes de Plantas , Telômero/genética , Evolução Molecular , Filogenia , Sequências Repetidas Terminais/genéticaRESUMO
Oxidative metabolism of [3H]diethylstilbestrol (DES) and the irreversible binding of reactive [3H]DES metabolites to the macromolecules in kidney slices of Syrian golden hamster were investigated. Non-extractable binding of [3H]DES to kidney macromolecules was observed after incubating hamster kidney slices under aerobic conditions (95% O2/5% CO2), but not under anaerobic conditions (100% nitrogen + 2 mM KCN). A number of oxidative metabolites of [3H]DES were detected in the incubation medium of kidney slices incubated under aerobic, but not anaerobic, conditions. The amount of radiolabeled macromolecules formed in male cortical slices under aerobic conditions increased with time of incubation. At a medium concentration of 50 nM [3H]DES, 0.08 pmole [3H]DES equiv./mg dry weight at 30 min and 0.19 pmole [3H]DES equiv./mg dry weight at 120 min were observed. The amount of irreversible [3H]DES-macromolecular complexes also increased with the concentration of [3H]DES in the incubation medium: 1.59 pmole [3H]DES equiv./mg dry weight was formed with 0.5 microM [3H]DES and 21.89 pmole [3H]DES equiv./mg dry weight was formed with 10 microM [3H]DES. Non-extractable [3H]DES binding was detected in all the subcellular fractions of hamster kidney with the highest amount in the microsomal and soluble fractions, followed by the mitochondrial and nuclear fractions. The macromolecular-[3H]DES complexes were solubilized by proteases but not nucleases, suggesting that [3H]DES irreversible binding is principally to the proteins and not the nucleic acids. The cortex as compared with the medulla of the male hamster kidney displayed a 5-fold greater capacity to irreversibly bind [3H]DES metabolites. The male hamster renal cortex showed a 2- to 3-fold greater capacity to form irreversible macromolecular-[3H]DES complexes than the female hamster renal cortex. These data demonstrate that: (1) renal oxidative metabolism of DES results in [3H]DES metabolites binding irreversibly to macromolecules; and (2) the sex and organ site specificity of the [3H]DES-macromolecular binding corresponds with the sex and organ site specificity of renal tumors of the hamster.
Assuntos
Dietilestilbestrol/metabolismo , Rim/metabolismo , Aerobiose , Anaerobiose , Animais , Cricetinae , Feminino , Córtex Renal/metabolismo , Medula Renal/metabolismo , Masculino , Mesocricetus , Cianeto de Potássio/farmacologia , Pronase/metabolismo , Fatores de TempoRESUMO
Big Blue (BB) and generic B6C3F1 mice were given one to three i.p. injections of 50 mg/kg benzo[a]pyrene (B[a]P) in DMSO every other day to achieve cumulative doses of 50 to 150 mg/kg. Three weeks after treatment, the mutation frequency at the endogenous hprt gene and lacI transgene was measured in splenic T cells. Generic mice given 50, 100, and 150 mg/kg B[a]P displayed induced hprt frequencies (observed hprt frequency minus control frequency) of 5.5 +/- 1.0, 11 +/- 2.0, and 19 +/- 2.6 x 10(-6), respectively (average +/- SEM). In contrast, BB mice given 50 and 150 mg/kg B[a]P displayed induced hprt frequencies of 0.9 +/- 0.6 and 9.1 +/- 1.5 x 10(-6). 32P postlabelling revealed that the lower hprt response in BB mice correlated with lower amounts of BP-DNA adducts in spleen, liver, and lung 24 hours after B[a]P exposure. Western blot analysis of liver samples from B[a]P-treated mice suggests that the reduced adduct load in turn may be due to lower P450 1A1 levels in BB mice. The frequency of induced, nonsectored blue plaques (observed blue plaque frequency minus control frequency) in BB mice receiving 50 and 150 mg/kg B[a]P was 41 +/- 9 and 134 +/- 10 x 10(-6) (15- to 40-fold higher than the induced hprt frequency in the same treated animals). Sectored plaques were observed in both control and B[a]P groups but their frequency showed no relationship to dose (sectored frequency in all groups was approximately 20 x 10(-6)). To test whether persistent DNA adducts in the packaged lambda vector were contributing to the observed blue plaque frequency, purified lambda-LIZ DNA was treated in vitro with B[a]P diol epoxide (BPDE), packaged, and plated on E. coli lawn cells. Treatment with BPDE did not produce significant increases in homogeneous blue plaques, suggesting that the majority of mutants obtained from B[a]P-treated BB mice occurred in vivo. These results indicate that B[a]P exposure produces many more mutations at the lacI transgene than at the endogenous hprt locus.
Assuntos
Proteínas de Bactérias/genética , Benzo(a)pireno/toxicidade , Proteínas de Escherichia coli , Hipoxantina Fosforribosiltransferase/genética , Camundongos Transgênicos/genética , Proteínas Repressoras/genética , Transgenes/efeitos dos fármacos , 7,8-Di-Hidro-7,8-Di-Hidroxibenzo(a)pireno 9,10-óxido/metabolismo , 7,8-Di-Hidro-7,8-Di-Hidroxibenzo(a)pireno 9,10-óxido/toxicidade , Animais , Proteínas de Bactérias/efeitos dos fármacos , Composição de Bases , Benzo(a)pireno/metabolismo , Carcinógenos/toxicidade , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/metabolismo , Adutos de DNA/efeitos dos fármacos , Adutos de DNA/metabolismo , Relação Dose-Resposta a Droga , Etilnitrosoureia/toxicidade , Feminino , Vetores Genéticos/efeitos dos fármacos , Hipoxantina Fosforribosiltransferase/efeitos dos fármacos , Repressores Lac , Fígado/efeitos dos fármacos , Fígado/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Testes de Mutagenicidade , Mutagênicos/toxicidade , Proteínas Repressoras/efeitos dos fármacos , Baço/efeitos dos fármacos , Baço/metabolismoRESUMO
Isoniazid (INH) continues to be an effective drug used for chemoprophylaxis and treatment of tuberculosis. Unfortunately, INH is associated with significant hepatotoxicity in up to 2% of individuals exposed, and if this adverse event is not recognized early it can be fatal. Research on INH-induced hepatotoxicity has been hampered by the lack of a suitable animal model that closely resembles the toxicity in humans. The mechanism of INH-induced hepatotoxicity is still unknown. The present study describes the development of a reliable model of INH-induced hepatotoxicity in rabbits. The protocol involves repeated injections of INH over a 2-day period, resulting in significant hepatic necrosis as indicated by elevations of plasma argininosuccinic acid lyase activity. Pretreatment with phenobarbital increased the occurrence of INH-induced hepatic necrosis from approximately 60% (9 out of 15 rabbits) with INH alone to more than 90% (13 out of 14 rabbits). Morphological indices were used to demonstrate the presence of INH-induced hepatotoxicity, and biochemical indices were used to demonstrate both the presence and severity of INH-induced hepatotoxicity in this model. This model may prove useful for further investigations into the mechanism of INH-induced hepatotoxicity.
Assuntos
Isoniazida/toxicidade , Cirrose Hepática Experimental/induzido quimicamente , Fígado/efeitos dos fármacos , Administração Oral , Análise de Variância , Animais , Argininossuccinato Liase/sangue , Modelos Animais de Doenças , Injeções Subcutâneas , Isoniazida/administração & dosagem , Fígado/metabolismo , Fígado/patologia , Cirrose Hepática Experimental/enzimologia , Masculino , CoelhosRESUMO
Positive outcomes of in vitro genotoxicity tests may not always occur as a consequence of direct reaction of a compound or a metabolite with DNA. To follow-up positive responses in in vitro tests, we developed two supplemental, cell-free assays to examine the potential of compounds and metabolites to directly damage DNA. Calf thymus DNA was used as the target for the direct detection of adducts by 32P-postlabeling/TLC and electrochemical detection, and alkaline gel electrophoresis was used to detect single-strand breakage of bacteriophage lambda DNA. To show that these assays would detect damage from relevant compounds, we examined nine human carcinogens (aflatoxin B1, busulfan, chlorambucil, cyclophosphamide, diethylstilbestrol, melphalan, 2-naphthylamine, phenacetin and potassium chromate). Each of the nine compounds produced a positive result for one or both endpoints. Using multifraction contact-transfer TLC, we detected 32P-labeled DNA adducts produced by aflatoxin B1, chlorambucil, diethylstilbestrol, melphalan, 2-naphthylamine, and potassium chromate (plus hydrogen peroxide). Aflatoxin B1, diethylstilbestrol and 2-naphthylamine required metabolic activation (induced rat liver S9) to generate DNA adducts. Although potassium chromate alone induced a slight increase in the content of 8-hydroxydeoxyguanosine (a promutagenic adduct produced by reactive oxygen species), addition of hydrogen peroxide greatly increased 8-hydroxydeoxyguanosine levels. The damage to lambda DNA by each human carcinogen (or metabolites), except diethylstilbestrol, was sufficient to generate single-strand breaks after neutral thermal hydrolysis at 70 degrees C. Chromate was a weak inducer of DNA fragmentation, but adding hydrogen peroxide to the reaction mixtures dramatically increased the DNA strand breakage. Our data suggest that these non-routine, acellular tests for determining direct DNA damage may provide valuable mechanistic insight for positive responses in cell-based genetic toxicology tests.
Assuntos
Carcinógenos/toxicidade , Dano ao DNA , DNA/efeitos dos fármacos , Animais , Adutos de DNA/análise , Eletroforese , Humanos , RatosRESUMO
Recently, Phillips et al. reported that small amounts of radioactivity derived from [14C]omeprazole were 'associated' with DNA purified from gastrointestinal tissues of treated rats (Mutagenesis 7, 277-283, 1992). We hypothesized that this radioactivity arose from omeprazole bound to contaminating protein in the DNA fraction (Mutagenesis 7, 395-396, 1992). Using rats injected with 35S-labeled amino acids, we found significant protein contamination (0.06 microgram of protein per microgram of DNA) in DNA purified from gastrointestinal tissues. Gastric mucous proteins represent likely candidates for binding of omeprazole in the rat model used by Phillips et al. To investigate this, we partially purified proteins from gastric mucus, incubated them with [14C]omeprazole, and then added these radiolabeled mucoproteins to homogenates of rat colon and duodenum before starting the DNA purification. Detectable amounts of the added mucoproteins remained in the DNA fraction, but none of the control protein, bovine serum albumin, remained with the DNA. Further characterization of the mucoproteins by hydroxyapatite chromatography indicated that a certain population of these proteins survived the DNA purification procedures. These data indicate that the association of omeprazole with DNA reported by Phillips et al. most probably is explained by binding of omeprazole to mucous glycoproteins (or other proteins present in the GI tract) that selectively survive DNA purification protocols.
Assuntos
DNA/isolamento & purificação , Mucosa Gástrica/metabolismo , Mucoproteínas/isolamento & purificação , Omeprazol/metabolismo , Aminoácidos , Animais , Cromatografia por Troca Iônica , DNA/metabolismo , Durapatita , Endopeptidase K , Etilmaleimida , Intestinos/química , Masculino , Ratos , Ratos Sprague-Dawley , Serina Endopeptidases , Espectrofotometria Ultravioleta , Radioisótopos de EnxofreRESUMO
Fifty-five undergraduate and 22 graduate students in occupational therapy were surveyed by using the Canfield-Lafferty Learning Styles Inventory. The results of the study indicate that their learning style preferences favor the learning conditions that permit knowing and liking the instructor personally, setting one's own objectives, and working alone and independently. The highest content and mode preferences for learning were working with people and engaging in direct experience, respectively. The lowest content and mode preferences were for working with numbers and for reading. Achievement expectations for grades were A and B. The findings are discussed.
Assuntos
Aprendizagem , Terapia Ocupacional/educação , Florida , Humanos , Ensino/métodosRESUMO
Mammalian atria possess bioactive peptides that are natriuretic-diuretic and potent relaxants of vascular and nonvascular smooth muscle. Characterization of the biological activity of rat atrial extracts indicates two major peaks, having apparent molecular weight of 20,000-30,000 (atriopeptigen) and less than 10,000 (atriopeptins). The amino acid sequence of atriopeptins I, II and III have been determined, and it has been found that their structures are only slightly different. Atriopeptin I (twenty-one amino acid residues); ser-ser-cys-phe-gly-gly-arg-ile-asp-arg-ile-gly-ala-gln-ser-gly-leu-gly- cys- asn-ser) relaxes intestinal but not vascular smooth muscle strips, and is natriuretic. Atriopeptins II and III (23 and 24 residues; the 21-sequence of I with the addition of phe-arg or phe-arg-tyr at the C-terminus, respectively) relax intestinal and vascular smooth muscle strips and are potent natriuretics. Since atriopeptigen and the atriopeptins exhibit similar biological effects the possibility of a precursor-product relationship was tested. Mild proteolytic digestion (1IU/ml trypsin) of atriopeptigen activates this peptide and reduces its apparent molecular weight. Examination of whether the atria of Krebs perfused isolated hearts released the bioactive atrial peptides revealed the presence in the cardiac effluent of a trypsin-labile substance that was natriuretic-diuretic and a smooth muscle relaxant. To determine which form of the atrial peptide (e.g. atriopeptigen or atriopeptin) is released by the atria the cardiac effluents were concentrated and partially purified. The cardiac effluent contained a substance(s) similar to atriopeptin, but did not appear to possess the less-active high molecular weight peptide, atriopeptigen.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Fator Natriurético Atrial/isolamento & purificação , Animais , Fator Natriurético Atrial/análise , Fator Natriurético Atrial/farmacologia , Bioensaio/métodos , Galinhas , Cromatografia Líquida de Alta Pressão , Diurese/efeitos dos fármacos , Átrios do Coração/análise , Peso Molecular , Relaxamento Muscular/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Natriurese/efeitos dos fármacos , Coelhos , Ratos , Ratos Endogâmicos , Reto/efeitos dos fármacosAssuntos
Líquidos Corporais/metabolismo , Proteínas Musculares/fisiologia , Equilíbrio Hidroeletrolítico , Sequência de Aminoácidos , Animais , Fator Natriurético Atrial , Pressão Sanguínea , Água Corporal/metabolismo , Encéfalo/metabolismo , GMP Cíclico/sangue , DNA/análise , Espaço Extracelular/metabolismo , Histocitoquímica , Homeostase , Humanos , Rim/fisiologia , Antagonistas de Receptores de Mineralocorticoides/farmacologia , Proteínas Musculares/genética , Proteínas Musculares/isolamento & purificação , Proteínas Musculares/farmacologia , Miocárdio/citologia , Natriurese , Radioimunoensaio , Circulação Renal , Renina/metabolismo , Sódio/metabolismo , Terminologia como AssuntoAssuntos
Cromatografia Líquida de Alta Pressão/métodos , DNA/química , Desoxiguanosina/análogos & derivados , 8-Hidroxi-2'-Desoxiguanosina , Animais , Biotecnologia , Química Encefálica , Bromatos/toxicidade , Carcinógenos/toxicidade , Bovinos , DNA/efeitos dos fármacos , DNA/isolamento & purificação , Desoxiguanosina/análise , Rim/química , Rim/efeitos dos fármacos , Fígado/química , Masculino , Ratos , Ratos Sprague-Dawley , Espectrofotometria Ultravioleta , Timo/químicaRESUMO
Integrin alpha4beta1 plays an important role in inflammatory processes by regulating the migration of leukocytes into inflamed tissues. Previously, we identified BIO5192 [2(S)-{[1-(3,5-dichloro-benzenesulfonyl)-pyrrolidine-2(S)-carbonyl]-amino}-4-[4-methyl-2(S)-(methyl-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-amino)-pentanoylamino]-butyric acid], a highly selective and potent (K(D) of 9 pM) small molecule inhibitor of alpha4beta1. Although BIO5192 is efficacious in various animal models of inflammatory disease, high doses and daily treatment of the compound are needed to achieve a therapeutic effect because of its relatively short serum half-life. To address this issue, polyethylene glycol modification (PEGylation) was used as an approach to improve systemic exposure. BIO5192 was PEGylated by a targeted approach in which derivatizable amino groups were incorporated into the molecule. Two sites were identified that could be modified, and from these, five PEGylated compounds were synthesized and characterized. One compound, 2a-PEG (K(D) of 19 pM), was selected for in vivo studies. The pharmacokinetic and pharmacodynamic properties of 2a-PEG were dramatically improved relative to the unmodified compound. The PEGylated compound was efficacious in a rat model of experimental autoimmune encephalomyelitis at a 30-fold lower molar dose than the parent compound and required only a once-a-week dosing regimen compared with a daily treatment for BIO5192. Compound 2a-PEG was highly selective for alpha4beta1. These studies demonstrate the feasibility of PEGylation of alpha4beta1-targeted small molecules with retention of activity in vitro and in vivo. 2a-PEG, and related compounds, will be valuable reagents for assessing alpha4beta1 biology and may provide a new therapeutic approach to treatment of human inflammatory diseases.